Efficacy of oral and non‐oral migraine prophylactic treatment on self‐reported subjective sleep quality in migraine patients with sleep problems: A review and meta‐analysis

W. P. J. van Oosterhout,L. Kanis,N. J. Wiendels,J. W. Reijngoudt
DOI: https://doi.org/10.1111/jsr.14241
2024-06-08
Journal of Sleep Research
Abstract:Summary This study aims to investigate the effects of oral and non‐oral migraine prophylaxis on subjective sleep quality in migraine patients with sleep problems. A bidirectional relationship between migraine and sleep is presumed, although this relationship is not fully clarified. Possibly, prophylactic treatment of migraine aiming at a reduction of migraine attack frequency can also positively affect the quality of sleep for patients with migraine with sleep problems. PubMed, Cochrane, Embase and CINAHL databases were searched in March 2022 for studies evaluating prophylactic treatment of migraine and the impact on perceived sleep quality (Pittsburgh Sleep Quality Index or Insomnia Severity Index). A systematic review using the McMaster Tool and a random‐effects meta‐analysis (effect size Cohen's d) were conducted. Seven studies were identified, including 989 participants, of which 844/989 (85.3%) female, with a mean (SD) age of 41.3 (12.1) years. In 6/7 (85.7%) studies, monthly migraine days improved (p 7, in >50% of participants). The meta‐analysis showed a large effect size of 1.09 (95% confidence interval 0.57–1.62; overall p
neurosciences,clinical neurology
What problem does this paper attempt to address?